CN102482210B - 维生素d受体激动剂及其用途 - Google Patents
维生素d受体激动剂及其用途 Download PDFInfo
- Publication number
- CN102482210B CN102482210B CN201080027380.8A CN201080027380A CN102482210B CN 102482210 B CN102482210 B CN 102482210B CN 201080027380 A CN201080027380 A CN 201080027380A CN 102482210 B CN102482210 B CN 102482210B
- Authority
- CN
- China
- Prior art keywords
- compound
- vida
- ethyl
- ylidene
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *C(C(C(*)C(C1*=*)=*)O*)C1O* Chemical compound *C(C(C(*)C(C1*=*)=*)O*)C1O* 0.000 description 3
- GIKVTXBRCGZTIJ-ZIFCJYIRSA-N CCS(CC)(CC)OCC([C@@H](CC1)[C@@](C)(CCC2)[C@@H]1C2=O)=C Chemical compound CCS(CC)(CC)OCC([C@@H](CC1)[C@@](C)(CCC2)[C@@H]1C2=O)=C GIKVTXBRCGZTIJ-ZIFCJYIRSA-N 0.000 description 1
- BCUOTFLJVDPGBL-OPRDCNLKSA-N CP[C@](C[O]=C)(C[C@H](C1=C)O)C[C@H]1ON Chemical compound CP[C@](C[O]=C)(C[C@H](C1=C)O)C[C@H]1ON BCUOTFLJVDPGBL-OPRDCNLKSA-N 0.000 description 1
- ASJRFLBVDDNRRS-CQUNGICBSA-N C[C@@H](CO[C@H](C)C(CC1)C(C)(CCC2)C1/C2=C/C=C(C[C@H](C12CC1)O)C[C@H]2O)C(C)(C)O Chemical compound C[C@@H](CO[C@H](C)C(CC1)C(C)(CCC2)C1/C2=C/C=C(C[C@H](C12CC1)O)C[C@H]2O)C(C)(C)O ASJRFLBVDDNRRS-CQUNGICBSA-N 0.000 description 1
- BJQQNQAJMFOLHJ-YIUBPGBESA-N C[C@@H](CO[C@H](C)C(CC1)C(C)(CCC2)C1C2O)C(C)(C)O Chemical compound C[C@@H](CO[C@H](C)C(CC1)C(C)(CCC2)C1C2O)C(C)(C)O BJQQNQAJMFOLHJ-YIUBPGBESA-N 0.000 description 1
- PHZUBLCGRIFVFA-AVDVATOESA-N C[C@@H](COc1cc(C(C)(C)O)ccc1)[C@@H](CC1)[C@@](C)(CCC2)[C@@H]1/C2=C/C=C(\C[C@H](C12CC1)O)/C[C@H]2[O]=C Chemical compound C[C@@H](COc1cc(C(C)(C)O)ccc1)[C@@H](CC1)[C@@](C)(CCC2)[C@@H]1/C2=C/C=C(\C[C@H](C12CC1)O)/C[C@H]2[O]=C PHZUBLCGRIFVFA-AVDVATOESA-N 0.000 description 1
- AWAVROQBXLYCIL-PHBZTJDLSA-N C[C@H](COc1ccccc1)[C@@H](CC1)[C@@](C)(CCC2)[C@@H]1/C2=C/C=C(C[C@H](C1=C)O)C[C@H]1O Chemical compound C[C@H](COc1ccccc1)[C@@H](CC1)[C@@](C)(CCC2)[C@@H]1/C2=C/C=C(C[C@H](C1=C)O)C[C@H]1O AWAVROQBXLYCIL-PHBZTJDLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/50—Spiro compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17016009P | 2009-04-17 | 2009-04-17 | |
| US61/170,160 | 2009-04-17 | ||
| PCT/US2010/030777 WO2010120698A1 (en) | 2009-04-17 | 2010-04-12 | Vitamin d receptor agonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102482210A CN102482210A (zh) | 2012-05-30 |
| CN102482210B true CN102482210B (zh) | 2015-04-08 |
Family
ID=42710758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080027380.8A Active CN102482210B (zh) | 2009-04-17 | 2010-04-12 | 维生素d受体激动剂及其用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20120115824A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2419403B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5665848B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102482210B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010236642B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2758698C (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ595727A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010120698A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8993547B2 (en) * | 2011-06-14 | 2015-03-31 | Wisconsin Alumni Research Foundation | 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses |
| CN105456278A (zh) * | 2014-09-03 | 2016-04-06 | 欣凯医药科技(上海)有限公司 | 一种抑制食欲的活性维生素d类似物 |
| CN105384765A (zh) * | 2014-09-04 | 2016-03-09 | 欣凯医药科技(上海)有限公司 | 奎宁酸内酯衍生物的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050004085A1 (en) * | 2003-07-03 | 2005-01-06 | Deluca Hector F. | 2-Methylene-19-nor-20(S)-25-methyl-1alpha-hydroxycalciferol and its uses |
| EP1559708A1 (en) * | 2002-10-10 | 2005-08-03 | Masato Shimizu | 2,2-DI-SUBSTITUTED 1a,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE |
| WO2009067578A2 (en) * | 2007-11-20 | 2009-05-28 | Abbott Laboratories | New vitamin d receptor activators and methods of making |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1559708A (en) * | 1924-04-11 | 1925-11-03 | Kelsey Walter Harrison | Mattress and method of making the same |
| JP3759639B2 (ja) * | 1994-04-11 | 2006-03-29 | 中外製薬株式会社 | 22−チアビタミン▲d3▼誘導体 |
| JPH10182597A (ja) * | 1996-10-29 | 1998-07-07 | Sumitomo Pharmaceut Co Ltd | 異性化ビタミンd誘導体 |
| US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
| WO1998052574A1 (en) * | 1997-05-22 | 1998-11-26 | Cephalon, Inc. | Vitamin d analogues and their neuronal effects |
| GB9819764D0 (en) * | 1998-09-10 | 1998-11-04 | Oxagen Limited | Method |
| IT1311921B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| US6673782B2 (en) * | 1999-04-29 | 2004-01-06 | Wisconsin Alumni Research Foundation | Treatment of systemic lupus erythematosis |
| US20030195175A1 (en) * | 2002-03-25 | 2003-10-16 | Deluca Hector F. | Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone |
| WO2004067504A1 (ja) * | 2003-01-31 | 2004-08-12 | Chugai Seiyaku Kabushiki Kaisha | 2位置換ビタミンd誘導体 |
| US20050209203A1 (en) * | 2003-07-30 | 2005-09-22 | Jin Tian | Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease |
-
2010
- 2010-04-12 EP EP10714143.4A patent/EP2419403B1/en active Active
- 2010-04-12 JP JP2012506099A patent/JP5665848B2/ja active Active
- 2010-04-12 NZ NZ595727A patent/NZ595727A/xx unknown
- 2010-04-12 AU AU2010236642A patent/AU2010236642B2/en active Active
- 2010-04-12 WO PCT/US2010/030777 patent/WO2010120698A1/en not_active Ceased
- 2010-04-12 CA CA2758698A patent/CA2758698C/en active Active
- 2010-04-12 US US13/264,280 patent/US20120115824A1/en not_active Abandoned
- 2010-04-12 CN CN201080027380.8A patent/CN102482210B/zh active Active
-
2018
- 2018-04-09 US US15/948,359 patent/US20180327354A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1559708A1 (en) * | 2002-10-10 | 2005-08-03 | Masato Shimizu | 2,2-DI-SUBSTITUTED 1a,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE |
| US20050004085A1 (en) * | 2003-07-03 | 2005-01-06 | Deluca Hector F. | 2-Methylene-19-nor-20(S)-25-methyl-1alpha-hydroxycalciferol and its uses |
| WO2009067578A2 (en) * | 2007-11-20 | 2009-05-28 | Abbott Laboratories | New vitamin d receptor activators and methods of making |
Non-Patent Citations (3)
| Title |
|---|
| Crystal Structures of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs:Structural Basis for Vitamin D Receptor Antagonism and Partial Agonism;Makoto Nakabayashi et al.;《J. Med. Chem.》;20080819;第51卷(第17期);5320–5329 * |
| Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases;Yvonne Bury et al.;《THE JOURNAL OF INVESTIGATIVE DERMATOLOGY》;20010531;第116卷(第5期);785-792 * |
| Synthesis and biological activities of new 1α,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain;Masato Shimizu et al.;《Bioorganic & Medicinal Chemistry》;20060224;第14卷;4277–4294 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012524091A (ja) | 2012-10-11 |
| NZ595727A (en) | 2013-11-29 |
| CA2758698C (en) | 2017-08-08 |
| CA2758698A1 (en) | 2010-10-21 |
| JP5665848B2 (ja) | 2015-02-04 |
| WO2010120698A1 (en) | 2010-10-21 |
| AU2010236642A1 (en) | 2011-11-03 |
| CN102482210A (zh) | 2012-05-30 |
| US20180327354A1 (en) | 2018-11-15 |
| EP2419403A1 (en) | 2012-02-22 |
| US20120115824A1 (en) | 2012-05-10 |
| AU2010236642B2 (en) | 2014-06-26 |
| EP2419403B1 (en) | 2016-09-07 |
| HK1166493A1 (zh) | 2012-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5544298B2 (ja) | 新規ビタミンd受容体賦活剤および製造方法 | |
| US7531527B2 (en) | 2-Propylidene-19-nor-vitamin D compounds | |
| JP2006096759A (ja) | 2−アルキル−19−ノル−ビタミンd化合物 | |
| JP2001504135A (ja) | 2−アルキリデン−19−ノル−ビタミンd化合物 | |
| KR100593238B1 (ko) | 비타민 d3 유도체 및 이로부터 제조된 염증성 호흡기 질환 치료제 | |
| US20180327354A1 (en) | Unnatural Analogues of Calcitriol and Uses Thereof | |
| JP2008515978A (ja) | カンナビネルジック脂質リガンド | |
| JP2001505527A (ja) | ピリジル置換されたc▲下13▼側鎖を有するタキサン誘導体、その製造方法および抗腫瘍剤としてのその使用 | |
| JPWO2010053165A1 (ja) | ビタミンd3ラクタム誘導体 | |
| JPWO1999043645A1 (ja) | 24−ヒドロキシビタミンd誘導体 | |
| HK1166493B (en) | Vitamin d receptor agonists and uses thereof | |
| JPH11500112A (ja) | 新規のボルネオール誘導体、その製造方法及び薬剤学的使用 | |
| HUT77669A (hu) | 18-Nor-D-vitamin vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EP1219599B1 (en) | Vitamin d derivatives having substituents at the 2 alpha-position | |
| JP2003519682A (ja) | 新規ビタミンd類似体 | |
| KR20150054011A (ko) | 9,10-세코프레그난 유도체 및 의약 | |
| EP0971916A1 (fr) | Derives de n-(arginyl)benzenesulfonamide et leur utilisation comme agents antithrombotiques | |
| HK1086817B (en) | 2- propylidene-19-nor-vitamin d compounds | |
| ITMI950032A1 (it) | Composti arilalchilenici | |
| JPWO2000064870A1 (ja) | 3−メチルビタミンd誘導体 | |
| JPWO2001016099A1 (ja) | 2α位に置換基を有するビタミンD誘導体 | |
| JPWO2000038692A1 (ja) | ビタミンd3誘導体を用いる嚢胞性線維症治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: VIDASYM CORP. Free format text: FORMER OWNER: VIDASYM LLC Effective date: 20130614 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20130614 Address after: Illinois USA Applicant after: Vidasym, Inc. Address before: Illinois USA Applicant before: VIDASYM, LLC |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120530 Assignee: CINKATE PHARM TECH (SHANGHAI) Co.,Ltd. Assignor: Vidasym, Inc. Contract record no.: 2015990000973 Denomination of invention: Vitamin d receptor agonists and uses thereof Granted publication date: 20150408 License type: Exclusive License Record date: 20151120 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210531 Address after: Building 7, Lane 720, Cailun Road, Zhangjiang hi tech, Pudong New Area, Shanghai Patentee after: CINKATE PHARM TECH (SHANGHAI) Co.,Ltd. Address before: Illinois USA Patentee before: Vidasym, Inc. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230412 Address after: 201203 3rd floor, building 3, Lane 67, libing Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: CINKATE PHARMACEUTICAL INTERMEDIATES Co.,Ltd. Address before: Building 7, Lane 720, Cailun Road, Zhangjiang High Tech, Pudong New Area, Shanghai, March 2012 Patentee before: CINKATE PHARM TECH (SHANGHAI) Co.,Ltd. |
|
| TR01 | Transfer of patent right |